Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

HCT-1026 reduces bone resorption in female patients with osteopenia

July 21, 2005

Sankyo to resume development of CS-917

July 20, 2005

MacroGenics signs agreement for anti-CD3 antibody for type 1 diabetes

July 20, 2005

PPARalpha/delta agonists show beneficial effects on HDL-C in primates

July 20, 2005

Triglide launched in U.S.

July 19, 2005

7TM Pharma begins phase I/II trials for TM-30338 for obesity

July 19, 2005

New agents for diabetes and related conditions reported in recent patents

July 18, 2005

Takeda acquires PPD's rights to DPP-IV inhibitors

July 18, 2005

Hemosol selects IGIV as first therapeutic protein product for development

July 15, 2005

Velcura receives SBIR for development of drugs for bone disorders

July 15, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...